Hi Mateo,
Hope your well.
I'm not sure if you watched the recent MST financial webinar (very impressive in my view). But they are expecting ATH434 to be used in early stages of PD, as MSA and PD affect similar regions of the brain in early stages, and therefore to hard to disseminate. Given this, Dr Stamler had mentioned ATH434 will be utilised in the treatment of PD.
Just have to cross the finish line and get the final readout.
Hi Mateo,Hope your well.I'm not sure if you watched the recent...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $32.63K | 10.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 21801548 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130971725 | 28 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |